Only one lawyer gets “Lawyer of the Year” recognition for each specialty and location
Best Lawyers has published its new lawyer and law firm ratings for 2021, and we are proud to highlight Lieff Cabraser Eric B. Fastiff’s selection as “Lawyer of the Year” for Antitrust Litigation for Northern California.
The oldest peer review publication in the legal profession, Best Lawyers strives to “capture the consensus opinion of leading lawyers” with its annual listing of the most highly regarded practitioners in the law. Further recognition is also awarded to “Lawyers of the Year,” individual lawyers with the highest overall peer-feedback for a specific practice area and geographic region; only one lawyer is recognized as the Lawyer of the Year for each specialty and location.
Best Lawyers’ choice of Eric as its Antitrust Law – Lawyer of the Year for Northern California reflects Eric’s unceasing work on behalf of clients in cases like the Cipro price-fixing and exclusionary drug-pricing agreements litigation, the TFT-LCD flat-panel global price-fixing conspiracy litigation, the class action litigation against De Beers for monopolization of the rough diamond trade, and groundbreaking California litigation filed on behalf of a proposed class of purchasers of bail bonds in California. This first-of-its-kind case alleges a conspiracy among sureties and bail agents to inflate bail bond prices.
Eric also currently represents The Charles Schwab Corporation in a suit against several major banks for alleged London Interbank Offered Rate (LIBOR) manipulation.
About Eric Fastiff
The chair of Lieff Cabraser’s Antitrust, Intellectual Property, and Commercial Litigation Practice Group, Eric B. Fastiff has practiced commercial litigation for the past 23 years in the drug, food, technology, finance, and natural resource industries. Eric served as co-lead counsel in the California Cipro litigation representing California consumers and third party payors in a state court class action lawsuit charging Bayer, Barr Labs, and other generic prescription drug manufacturers with a conspiracy to restrain competition in the sale of Bayer’s blockbuster antibiotic drug Ciprofloxacin, sold as Cipro. The 17-year litigation ultimately resulted in settlements totaling $399 million.
Eric currently represents The Charles Schwab Corporation in a suit against several major banks for alleged LIBOR manipulation. Eric’s notable successes include representing businesses that purchased TFT-LCD panels and products in litigation charging that the world’s leading manufacturers conspired to fix prices, resulting in settlements totaling over $470 million. Eric also spearheaded prosecution of class action litigation against De Beers for monopolization of the rough diamond trade, resulting in a $295 million settlement.